Benzoic Acid

Benzoic Acid

SCHEMBL4158962

C=CC.O=C(O)c1ccccc1.O=C(O)c1ccccc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.70
DAO P14920 1/20 0.70
NAPRT Q6XQN6 1/20 0.70
CES2 O00748 4/20 0.58
CES1 P23141 4/20 0.58
SRD5A2 P31213 2/20 0.58
AKT1 P31749 1/20 0.56
TP53 P04637 1/20 0.52
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TRPA1 O75762 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP2C8 P10632 1/20 0.45
CYP2C9 P11712 1/20 0.45
KMO O15229 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL1434863 1.00 TSHR (0.70) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL9644655 1.00 TSHR (0.70) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL11340972 0.98 TSHR (0.67) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL21145058 0.98 TSHR (0.67) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL2921097 0.91 TSHR (0.58) TSHRDAONAPRTCES2CES1
Terephthalic Acid SCHEMBL15050 0.90 TSHR (0.67) TSHRDAONAPRTCES2CES1
Terephthalic Acid SCHEMBL28737896 0.90 TSHR (0.67) TSHRDAONAPRTCES2CES1
Terephthalic Acid SCHEMBL16470220 0.90 TSHR (0.67) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL15300262 0.87 TSHR (0.74) TSHRDAONAPRTCES2CES1
Terephthalic Acid SCHEMBL11664464 0.87 TSHR (0.63) TSHRDAONAPRTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102405131-A Indicator for detecting the presence of microbial metabolic byproducts INDICATOR SYSTEMS INTERNATIONA 2012-04-04 CN claimed
EP-1112174-B1 ISOSORBIDE CONTAINING POLYESTERS AND METHODS FOR MAKING SAME DU PONT (US) 2009-07-01 EP claimed
US-20260146118-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL KURARAY CO., LTD. (JP) 2026-05-28 US disclosed
EP-4606825-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL Kuraray Co., Ltd. (JP) 2025-08-27 EP disclosed
WO-2024085035-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL 株式会社クラレ 2024-04-25 WO disclosed
CN-113710710-A Method for producing propylene polymer 住友化学株式会社 2021-11-26 CN disclosed
EP-2726447-B1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH & CIE (CH) 2015-08-12 EP disclosed
US-9056826-B2 Process for the preparation of beta-santalol FIRMENICH SA (CH) 2015-06-16 US disclosed
US-20140213818-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2014-07-31 US disclosed
EP-2726447-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL Firmenich SA (CH) 2014-05-07 EP disclosed
WO-2013001026-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2013-01-03 WO disclosed
US-6759107-B1 THERMOPLASTIC RESIN, TRANSITION METAL SALT, MULTILAYERED POLYMER PARTICLE COMPRISING A CONJUGATED DIENE MONOMER KURARAY CO., LTD. (JP) 2004-07-06 US disclosed
CN-1487905-A Sized glass yarns, sizing compositions and composites containing said yarns ����ʥ���Τ������˹���޹�˾ 2004-04-07 CN disclosed
EP-1067154-A2 Thermoplastic resin composition and multilayered container using the same Kuraray Co., Ltd. (JP) 2001-01-10 EP disclosed
US-5574078-A INK COLOR CONCENTRATES WITH IONOMERS FOR INKS LASERMASTER CORPORATION (US) 1996-11-12 US disclosed
EP-0165383-B1 RESINOUS COMPOSITION KURARAY CO., LTD. (JP) 1993-06-09 EP disclosed
US-4774114-A FOR CARBONATED BEVERAGES, POLYESTER AND SAPONIFIED ETHYLENE-VINYL ACETATE KURARAY CO., LTD. (JP) 1988-09-27 US disclosed
EP-0165383-A2 Resinous composition KURARAY CO., LTD. (JP) 1985-12-27 EP disclosed
US-4284671-A BLENDS WITH ETHYLENE-VINYL ALCOHOL COPOLYMER; FOR PACKAGING CLOPAY CORPORATION (US) 1981-08-18 US disclosed
EP-0019438-A1 Polyester compositions for gas and moisture barrier materials, barrier materials formed from said compositions and a container formed from a layer of said barrier material CLOPAY CORPORATION (US) 1980-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213818-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL ACSL3, ACSL1, CSNK1A1L TSHR 2364/4885DAO 507/4885NAPRT 1604/4885
US-20260146118-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL ADH1A, GK, ADH1C TSHR 2692/4885DAO 3268/4885NAPRT 4760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.